| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 13, 2020
Salt Lake City, Utah – February 13, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 13, 2020
Salt Lake City, Utah – February 13, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 11, 2020
Salt Lake City, Utah – February 11, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today...
-
Feb 10, 2020
Salt Lake City, Utah – February 10, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 6, 2020Product launch and rapid development of the Logix Smart™ 2019-nCoV coronavirus test facilitated by Company’s proprietary technology platform
Salt Lake City, Utah – February 6, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Feb 4, 2020Coronavirus assay will be addressed in webinar, as well as development of an innovative multiplex application of Company’s technology for mosquito populations
Salt Lake City, Utah – February 4, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Jan 31, 2020Components of recently designed novel coronavirus assay have successfully passed initial verification
Salt Lake City, Utah – January 30, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Jan 30, 2020Co-Diagnostics Inc CEO Interviewed on Fox Business with Maria Bartiromo as Coronavirus Concerns RiseInterviews on Fox Business and other programs discussed issues surrounding the novel strain of the coronavirus and the Company’s plan to provide a diagnostic solution
Salt Lake City, Utah – January 30, 2020 – The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic...
-
Jan 29, 2020
Salt Lake City, Utah – January 29, 2020 – Co-Diagnostics, Inc. (Nasdaq: CODX), was recently featured in an article on BioWorld titled “Co-Diagnostics completes critical step in developing...
-
Jan 28, 2020Interview covered method of transmission, importance of accurate diagnostic tools, and the Company diagnostic announced last week
Salt Lake City, Utah – January 28, 2020 – The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic...
-
Jan 28, 2020
Salt Lake City, Utah – January 28, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 24, 2020
Salt Lake City, Utah – January 24, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 23, 2020Proprietary Company design process facilitates rapid response to health emergencies
Salt Lake City, Utah – January 23, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 14, 2020Co-Diagnostics’ CoPrimer platform, licensed by LGC, Biosearch, successfully used by Bayer to develop assays for multiplex PCR
Salt Lake City, Utah – January 9, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 9, 2020
Salt Lake City, Utah – January 9, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 7, 2020
Salt Lake City, Utah – January 7, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Jan 2, 2020CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus recently granted regulatory approval by CDSCO to formally launch at India Diagnostic Expo
Salt Lake City, Utah – January 2, 2020 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of...
-
Dec 11, 2019
Salt Lake City, Utah – December 11, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), was recently featured in an article on genomeweb.com titled “Co-Diagnostics Continues Global Expansion With...
-
Dec 10, 2019Vector Smart™ NAM-e multiplex PCR test to provide proactive defense against mosquito populations carrying the deadly eastern equine encephalitis virus
Salt Lake City, Utah – December 10, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Dec 3, 2019CoSara Saragene™ tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus now available for sale and distribution as in vitro diagnostics
Salt Lake City, Utah – December 3, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Nov 13, 2019Revenue includes sales of infectious disease, mosquito abatement products and AgBio primer design services
Salt Lake City, Utah – November 13, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Nov 8, 2019
Following recent Company news of expansion into Africa with the sale and installation to one of the largest private molecular diagnostics laboratories in Ghana, Co-Diagnostics, Inc. (Nasdaq:...
-
Oct 29, 2019Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana
Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests,...
-
Oct 15, 2019Vector Smart™ products being presented at 6 vector control conferences in October to prepare for 2020 mosquito season
Salt Lake City, Utah – October 15, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Oct 10, 2019Vector Smart™ ZDC multiplex PCR test to aid prevention of tropical disease proliferation in the US and abroad
Salt Lake City, Utah – October 10, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Oct 3, 2019
Salt Lake City, Utah – October 3, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Sep 19, 2019Company will host booth to introduce and promote mosquito abatement products to midwestern states in Tulsa, OK on Sept 19-20
Salt Lake City, Utah – September 19, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Sep 4, 2019Expansion to include increased royalties and cover additional applications for Company’s technology platform
Salt Lake City, Utah – September 4, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
-
Aug 28, 2019
Salt Lake City, Utah – August 28, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Aug 21, 2019Event to include demos and training for distributors and end-users of Company’s products
Salt Lake City, Utah – August 21, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Aug 14, 2019Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum
Salt Lake City, Utah – August 14, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Aug 1, 2019Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation
Salt Lake City, Utah – August 1, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 30, 2019
Salt Lake City, Utah – July 30, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 18, 2019
Salt Lake City, Utah – July 18, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jul 11, 2019
Salt Lake City, Utah – July 11, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jun 27, 2019
Salt Lake City, Utah – June 27, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jun 25, 2019
Salt Lake City, Utah – June 25, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
May 22, 2019
Salt Lake City, Utah – May 22, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
May 15, 2019
Salt Lake City, Utah – May 15, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Apr 30, 2019Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less
Salt Lake City, Utah – April 30, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Apr 16, 2019CoSara Diagnostics facility to be among the first of its kind in India
Salt Lake City, Utah – April 16, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Apr 2, 2019
Salt Lake City, Utah – April 02, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Mar 14, 2019Conference hosted at US corporate headquarters to include training for distributors and end-users of Company’s diagnostic, research, and vector-control products
Salt Lake City, Utah – March 14, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Mar 7, 2019Logix Smart™ ZDC Test now available for export from the United States as a CE-marked IVD
Salt Lake City, Utah – March 7, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Feb 26, 2019Company’s multiplexed Logix Smart™ ZDC Test to be available for purchase with CE mark in March 2019
Salt Lake City, Utah – February 26, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
-
Feb 22, 2019
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Feb 21, 2019Trainings will be conducted for staff and customers of Laboratorios Franja, including demonstrations of Company’s vector control products
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Feb 4, 2019
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today...
-
Jan 30, 2019Transaction included $3M of preferred shares, and the elimination of $2M of debt
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
-
Jan 30, 2019
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today...